Llewellyn King interviews Linda Marban, CEO of Capricor Therapeutics, a Los Angeles-based clinical-stage biotech company. Their discussion centers on where biomedical research across the board stands, and the positive fallout for ME/CFS from research on COVID-19 and other diseases.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
